SULFONYLUREA FAILURE IN TYPE-2 DIABETES - TREATMENT WITH A BASAL INSULIN SUPPLEMENT

被引：69
|
作者：
HOLMAN, RR
STEEMSON, J
TURNER, RC
机构：
来源：
DIABETIC MEDICINE | 1987年 / 4卷 / 05期
关键词：
D O I：
10.1111/j.1464-5491.1987.tb00909.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：457 / 462
页数：6
相关论文
共 50 条
  • [41] INTERMEDIATE ACTING INSULIN FOR TYPE-2 DIABETES
    TURNER, R
    HOLMAN, R
    LANCET, 1985, 1 (8429): : 640 - 640
  • [42] INSULIN-RESISTANCE AND TYPE-2 DIABETES
    SCHERNTHANER, G
    WIENER KLINISCHE WOCHENSCHRIFT, 1994, 106 (24) : 749 - 749
  • [43] Dose titration model and correlative factors analysis in Chinese patients with type-2 diabetes on basal insulin - results from an Observational Registry of Basal Insulin Treatment study
    Chen, Jing
    Chen, Ying-Li
    Ji, Li-Nong
    Zhang, Pu-Hong
    Zhu, Dong-Shan
    Li, Xian
    Ji, Jia-Chao
    Zhao, Fang
    Zhang, Heng
    ENDOKRYNOLOGIA POLSKA, 2018, 69 (04) : 395 - 402
  • [44] SULFONYLUREA AND INSULIN - COMBINED TREATMENT IN TYPE-1 (INSULIN-DEPENDENT) DIABETES
    BURKE, BJ
    DIABETOLOGIA, 1985, 28 (03) : 182 - 182
  • [45] The Molecular Genetics of Sulfonylurea Receptors in the Pathogenesis and Treatment of Insulin Secretory Disorders and Type 2 Diabetes
    Veronica Lang
    Nermeen Youssef
    Peter E. Light
    Current Diabetes Reports, 2011, 11 : 543 - 551
  • [46] The Molecular Genetics of Sulfonylurea Receptors in the Pathogenesis and Treatment of Insulin Secretory Disorders and Type 2 Diabetes
    Lang, Veronica
    Youssef, Nermeen
    Light, Peter E.
    CURRENT DIABETES REPORTS, 2011, 11 (06) : 543 - 551
  • [47] TWICE DAILY INSULIN THERAPY IN PATIENTS WITH TYPE-2 DIABETES AND SECONDARY FAILURE TO SULFONYLUREAS
    WOLFFENBUTTEL, BHR
    WEBER, RFA
    WEEKS, L
    VANKOETSVELD, PM
    VERSCHOOR, L
    DIABETES RESEARCH CLINICAL AND EXPERIMENTAL, 1990, 13 (02): : 79 - 84
  • [48] IS INSULIN-TREATMENT SUFFICIENTLY USED IN TYPE-2 DIABETES - MINIMAL OR INTENSIFIED INSULIN THERAPY
    CHARBONNEL, B
    DIABETES & METABOLISM, 1995, 21 (03): : 219 - 224
  • [49] ADHERENCE TO INITIATED BASAL INSULIN ANALOG TREATMENT IN TYPE 1 AND 2 DIABETES
    Westerbacka, J.
    Mihailov, H.
    Valle, T.
    Jaaskelainen, S.
    Kaukua, J.
    VALUE IN HEALTH, 2015, 18 (07) : A612 - A612
  • [50] Treatment Costs of Basal Insulin Regimens for Type 2 Diabetes Mellitus in France
    Bruno Detournay
    Zahra Boultif
    Amar Bahloul
    Viviane Jeanbat
    Julien Robert
    PharmacoEconomics - Open, 2021, 5 : 211 - 219
12345